BLE3 Antibody

What are the validated applications for BLE3 antibody in plant research?

According to available data, BLE3 antibody (CSB-PA387251XA01OFF-10) has been validated for Western blotting and ELISA applications in plant samples . These techniques allow for:

• Western blotting: Detection of BLE3 protein expression levels in different plant tissues or under various experimental conditions

• ELISA: Quantitative measurement of BLE3 protein in plant extracts

When designing experiments, researchers should include appropriate positive controls, such as the recombinant immunogen protein provided with the antibody (200μg), to validate detection specificity.

What are the storage and handling recommendations for maintaining BLE3 antibody activity?

BLE3 antibody should be stored at -20°C or -80°C for long-term preservation of activity . When handling:

• Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt

• Transport using blue ice as specified by the supplier

• For working dilutions, store at 4°C for short periods (1-2 weeks)

• Centrifuge briefly before opening to collect solution at the bottom of the tube

These handling practices are methodologically important as they preserve epitope recognition capacity and prevent non-specific binding in experimental applications.

How can BLE3 antibody be used to investigate plant responses to environmental stressors?

Methodological approach for studying stress responses with BLE3 antibody:

• Subject plant samples to controlled stress conditions (drought, salinity, temperature)

• Harvest tissues at multiple time points post-stress application

• Process samples for protein extraction using plant-specific buffers containing protease inhibitors

• Quantify BLE3 expression changes via Western blotting or ELISA

• Correlate protein expression changes with physiological parameters and transcriptional responses

This approach allows researchers to determine if BLE3 is part of stress-responsive pathways in rice and related species, potentially identifying novel roles in plant adaptation mechanisms.

What approaches can be used to validate BLE3 antibody specificity in transgenic plant systems?

Rigorous validation in transgenic systems requires:

• Generate BLE3 knockout/knockdown lines using CRISPR-Cas9 or RNAi approaches

• Create BLE3 overexpression lines with epitope tags (HA, FLAG, etc.)

• Perform parallel detection with BLE3 antibody and tag-specific antibodies

• Conduct peptide competition assays using the recombinant immunogen protein

• Perform immunoprecipitation followed by mass spectrometry to confirm target identity

How can BLE3 antibody be incorporated into high-throughput phenotyping of crop varieties?

High-throughput applications methodology:

• Develop a standardized protein extraction protocol compatible with robotics

• Optimize ELISA conditions for BLE3 detection in 96 or 384-well format

• Establish calibration curves using recombinant BLE3 protein

• Process multiple varieties/accessions in parallel with biological replicates

• Correlate BLE3 expression levels with phenotypic traits of interest

• Apply statistical approaches (PCA, clustering) to identify patterns across germplasm

This methodological framework allows researchers to assess whether BLE3 expression levels correlate with desirable agronomic traits in breeding populations.

What are the optimal protein extraction methods for BLE3 detection in different plant tissues?

Effective protein extraction is critical for successful antibody applications. For BLE3:

• For leaf tissue: Use buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail

• For root tissue: Modified buffer with higher detergent concentration (2% Triton X-100) may improve extraction efficiency

• For seed tissue: Include additional steps to remove interfering storage proteins and starch

Sample homogenization should be performed at 4°C, and extracts cleared by centrifugation at >12,000g for 15 minutes before antibody applications to reduce background signal.

What are the recommended dilutions and blocking conditions for BLE3 antibody in Western blotting?

While optimal dilutions should be determined empirically for each experimental system , general guidelines include:

• Primary antibody (BLE3): Start with 1:1000 dilution in TBST with 5% non-fat milk or BSA

• Secondary antibody: Anti-rabbit IgG at 1:5000-1:10000 dilution

• Blocking: 5% non-fat milk in TBST for 1-2 hours at room temperature

• Membrane washing: 3-5 washes with TBST, 5 minutes each

• Incubation time: Overnight at 4°C for primary antibody; 1 hour at room temperature for secondary

For challenging tissues or low abundance targets, signal enhancement systems may be necessary, with adjusted antibody concentrations accordingly.

How should researchers quantify and normalize BLE3 expression data in comparative studies?

Methodological approach to quantification:

• Use digital imaging systems with linear detection range for Western blots

• Apply local background subtraction for each lane

• Normalize BLE3 signal to:

  • Total protein loading (Ponceau S, SYPRO Ruby)

  • Constitutively expressed reference proteins (actin, tubulin, GAPDH)

• Perform at least three biological replicates

• Apply appropriate statistical tests based on data distribution

What strategies can address inconsistent BLE3 detection across plant samples?

When facing detection inconsistencies:

• Evaluate protein extraction efficiency across samples using BCA or Bradford assays

• Test multiple extraction buffers with different detergent compositions

• Adjust antibody concentration and incubation conditions

• Check for post-translational modifications that might affect epitope recognition

• Consider sample enrichment via immunoprecipitation before detection

• Validate antibody lot consistency using reference samples

These methodological adjustments can help distinguish between biological variation in BLE3 expression and technical artifacts in detection.

How can researchers distinguish between specific and non-specific signals when using BLE3 antibody?

Methodological approaches to confirm signal specificity:

• Include the recombinant immunogen protein (provided with the antibody) as a positive control

• Perform peptide competition assays to block specific binding

• Include samples from tissues known to lack BLE3 expression as negative controls

• Compare patterns observed with predicted molecular weight (check for unexpected bands)

• Validate with orthogonal methods (mass spectrometry, RNA expression)

For ELISA applications, standard curve linearity and parallelism with sample dilutions provide additional validation of specific detection.

What approaches help resolve cross-reactivity issues with BLE3 antibody in closely related plant species?

When working across species:

• Perform sequence alignment of BLE3 orthologs to identify conservation of the immunogen region

• Titrate antibody concentrations to minimize cross-reactivity while maintaining specific signal

• Modify blocking conditions (try BSA instead of milk, or vice versa)

• Consider custom antibody development against species-specific epitopes for comparative studies

• Validate signal in each species using genetic approaches (RNAi, CRISPR)

Cross-reactivity can be beneficial for studying BLE3 across species but requires careful validation to ensure that observed signals represent true orthologs.

How does the performance of polyclonal BLE3 antibody compare to monoclonal antibodies in plant research applications?

While no specific monoclonal antibodies against BLE3 are described in the available data, general comparative considerations include:

Methodologically, researchers should choose between polyclonal and monoclonal approaches based on their experimental needs, with polyclonals like the available BLE3 antibody offering advantages in sensitivity and epitope robustness.

What experimental designs allow for simultaneous detection of BLE3 and interacting proteins?

To study protein-protein interactions involving BLE3:

• Co-immunoprecipitation using BLE3 antibody followed by mass spectrometry

• Proximity ligation assays to detect in situ protein interactions

• Sequential immunoprecipitation for complex purification

• Dual immunofluorescence with BLE3 and candidate interactor antibodies

• Split reporter systems (BiFC, FRET) for validation of direct interactions

These approaches require careful antibody validation and appropriate controls to distinguish true interactions from non-specific binding or co-localization.

How can researchers integrate BLE3 antibody-based detection with transcriptomic and metabolomic analyses?

Multi-omics integration methodology:

• Design experiments with matched samples for protein, RNA, and metabolite extraction

• Quantify BLE3 protein levels using Western blotting or ELISA

• Measure BLE3 transcript abundance via qRT-PCR or RNA-seq

• Analyze metabolite profiles using targeted or untargeted approaches

• Apply correlation analyses to identify relationships between:

  • BLE3 protein and transcript levels

  • BLE3 expression and specific metabolite abundances

  • Regulatory network components affecting both transcription and translation

This integrated approach allows researchers to determine whether BLE3 regulation occurs primarily at transcriptional, translational, or post-translational levels, and identify metabolic pathways potentially influenced by BLE3 function.